ArticleAllergy2025

Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study.

R Soegiharto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.